Evidence map›Paper›PMID 33005663›Full record

ArticleJournal of advanced veterinary and animal research2020

Comparative efficacy of commercial ylang-ylang (

Tanawat Chaiphongpachara, Sedthapong Laojun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of advanced veterinary and animal research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tanawat ChaiphongpacharaDepartment of Public Health and Health Promotion, College of Allied Health Sciences, Suan Sunandha Rajabhat University, Bangkok, Thailand.
Sedthapong LaojunDepartment of Public Health and Health Promotion, College of Allied Health Sciences, Suan Sunandha Rajabhat University, Bangkok, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe objective of this study was to determine the comparative larvicidal efficacy of commercial ylang-ylang MATERIALS AND

methodsThe bioassay for the larvicidal activity of commercial ylang-ylang essential oils in this experiment was modified from the World Health Organization standard protocols. The concentration ranges at 0.025, 0.050, 0.075, 0.100, 0.125, and 0.150 ppm in each treatment were used for testing, and four replicates were used per concentration. The larval mortality was observed and recorded 24- and 48-h after exposure.

resultsThe results of this study clearly revealed that commercial ylang-ylang essential oils from India and Thailand were highly toxic to the larvae of the dengue vector

conclusionThis study revealed the efficacy of commercial Indian and Thai ylang-ylang essential oils as natural vector control for the larval stage of the dengue vector

Indexed as

Aedes aegyptiCananga odoratadengue vectoressential oilsylang-ylang

Identifiers

PMID33005663
PMCPMC7521804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.